Gallagher Fiduciary Advisors, LLC Agios Pharmaceuticals, Inc. Transaction History
Gallagher Fiduciary Advisors, LLC
- $468 Million
- Q3 2024
A detailed history of Gallagher Fiduciary Advisors, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Gallagher Fiduciary Advisors, LLC holds 10,322 shares of AGIO stock, worth $328,652. This represents 0.1% of its overall portfolio holdings.
Number of Shares
10,322
Previous 6,940
48.73%
Holding current value
$328,652
Previous $299,000
53.18%
% of portfolio
0.1%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding AGIO
# of Institutions
232Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$180 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$177 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$155 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$119 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$90.2 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.75B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...